Literature DB >> 15753251

Application of monoclonal antibodies in functional and comparative investigations of heavy-chain immunoglobulins in new world camelids.

L P Daley1, L F Gagliardo, M S Duffy, M C Smith, J A Appleton.   

Abstract

Of the three immunoglobulin G (IgG) isotypes described to occur in camelids, IgG2 and IgG3 are distinct in that they do not incorporate light chains. These heavy-chain antibodies (HCAbs) constitute approximately 50% of the IgG in llama serum and as much as 75% of the IgG in camel serum. We have produced isotype-specific mouse monoclonal antibodies (MAbs) in order to investigate the roles of HCAbs in camelid immunity. Seventeen stable hybridomas were cloned, and three MAbs that were specific for epitopes on the gamma chains of llama IgG1, IgG2, or IgG3 were characterized in detail. Affinity chromatography revealed that each MAb bound its isotype in solution in llama serum. The antibodies bound to the corresponding alpaca IgGs, to guanaco IgG1 and IgG2, and to camel IgG1. Interestingly, anti-IgG2 MAbs bound three heavy-chain species in llama serum, confirming the presence of three IgG2 subisotypes. Two IgG2 subisotypes were detected in alpaca and guanaco sera. The MAbs detected llama serum IgGs when they were bound to antigen in enzyme-linked immunosorbent assays and were used to discern among isotypes induced during infection with a parasitic nematode. Diseased animals, infected with Parelaphostrongylus tenuis, did not produce antigen-specific HCAbs; rather, they produced the conventional isotype, IgG1, exclusively. Our data document the utility of these MAbs in functional and physiologic investigations of the immune systems of New World camelids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753251      PMCID: PMC1065209          DOI: 10.1128/CDLI.12.3.380-386.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  34 in total

1.  The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation.

Authors:  B P Woolven; L G Frenken; P van der Logt; P J Nicholls
Journal:  Immunogenetics       Date:  1999-10       Impact factor: 2.846

2.  Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae.

Authors:  L G Frenken; R H van der Linden; P W Hermans; J W Bos; R C Ruuls; B de Geus; C T Verrips
Journal:  J Biotechnol       Date:  2000-02-28       Impact factor: 3.307

3.  Potent enzyme inhibitors derived from dromedary heavy-chain antibodies.

Authors:  M Lauwereys; M Arbabi Ghahroudi; A Desmyter; J Kinne; W Hölzer; E De Genst; L Wyns; S Muyldermans
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

4.  The specific variable domain of camel heavy-chain antibodies is encoded in the germline.

Authors:  V K Nguyen; S Muyldermans; R Hamers
Journal:  J Mol Biol       Date:  1998-01-23       Impact factor: 5.469

5.  Comparison of llama VH sequences from conventional and heavy chain antibodies.

Authors:  K B Vu; M A Ghahroudi; L Wyns; S Muyldermans
Journal:  Mol Immunol       Date:  1997 Nov-Dec       Impact factor: 4.407

6.  Camelid heavy-chain variable domains provide efficient combining sites to haptens.

Authors:  S Spinelli; L G Frenken; P Hermans; T Verrips; K Brown; M Tegoni; C Cambillau
Journal:  Biochemistry       Date:  2000-02-15       Impact factor: 3.162

7.  Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama.

Authors:  R van der Linden; B de Geus; W Stok; W Bos; D van Wassenaar; T Verrips; L Frenken
Journal:  J Immunol Methods       Date:  2000-06-23       Impact factor: 2.303

8.  Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies.

Authors:  V K Nguyen; R Hamers; L Wyns; S Muyldermans
Journal:  Mol Immunol       Date:  1999-06       Impact factor: 4.407

9.  Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire.

Authors:  V K Nguyen; R Hamers; L Wyns; S Muyldermans
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

10.  Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate.

Authors:  T R Transue; E De Genst; M A Ghahroudi; L Wyns; S Muyldermans
Journal:  Proteins       Date:  1998-09-01
View more
  17 in total

1.  Contributions of conventional and heavy-chain IgG to immunity in fetal, neonatal, and adult alpacas.

Authors:  L P Daley-Bauer; S R Purdy; M C Smith; L F Gagliardo; W C Davis; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Analysis of heavy-chain antibody responses and resistance to Parelaphostrongylus tenuis in experimentally infected alpacas.

Authors:  S R Purdy; L F Gagliardo; S Lefman; P J S Hamel; S Ku; T Mainini; G Hoyt; K Justus; L P Daley-Bauer; M S Duffy; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

3.  Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct.

Authors:  Kevin A Henry; Henk van Faassen; Doreen Harcus; Anne Marcil; Jennifer J Hill; Serge Muyldermans; C Roger MacKenzie
Journal:  Immunogenetics       Date:  2019-01-18       Impact factor: 2.846

4.  Effector functions of camelid heavy-chain antibodies in immunity to West Nile virus.

Authors:  L P Daley; M A Kutzler; B W Bennett; M C Smith; A L Glaser; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2009-12-02

5.  A general protocol for the generation of Nanobodies for structural biology.

Authors:  Els Pardon; Toon Laeremans; Sarah Triest; Søren G F Rasmussen; Alexandre Wohlkönig; Armin Ruf; Serge Muyldermans; Wim G J Hol; Brian K Kobilka; Jan Steyaert
Journal:  Nat Protoc       Date:  2014-02-27       Impact factor: 13.491

6.  Evaluation of antidiphtheria toxin nanobodies.

Authors:  Ghada H Shaker
Journal:  Nanotechnol Sci Appl       Date:  2010-06-17

7.  Use of the single cell gel electrophoresis (comet assay) for comparing apoptotic effect of conventional antibodies versus nanobodies.

Authors:  Ghada H Shaker; Nahla A Melake
Journal:  Saudi Pharm J       Date:  2011-12-02       Impact factor: 4.330

8.  Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).

Authors:  David R Maass; Jorge Sepulveda; Anton Pernthaner; Charles B Shoemaker
Journal:  J Immunol Methods       Date:  2007-05-15       Impact factor: 2.303

9.  Isolation of a highly thermal stable lama single domain antibody specific for Staphylococcus aureus enterotoxin B.

Authors:  Russell R Graef; George P Anderson; Katherine A Doyle; Dan Zabetakis; Felicia N Sutton; Jinny L Liu; Joseline Serrano-González; Ellen R Goldman; Lynn A Cooper
Journal:  BMC Biotechnol       Date:  2011-09-21       Impact factor: 2.563

10.  Selection of nanobodies that target human neonatal Fc receptor.

Authors:  Jan Terje Andersen; Maria Gonzalez-Pajuelo; Stian Foss; Ole J B Landsverk; Débora Pinto; Alexander Szyroki; Hans J de Haard; Michael Saunders; Peter Vanlandschoot; Inger Sandlie
Journal:  Sci Rep       Date:  2013-01-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.